Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients

Stopped too many patients were expected and the investigative team would not be able to recruit this number

Conditions

• Shock
• Systemic Inflammatory Response Syndrome (SIRS)
• Hypoalbuminaemia

Interventions

• DRUG: Human serum albumin infusion 4%
• DRUG: Human serum albumin infusion 20%

Sponsor

University Hospital, Strasbourg, France